AstraZeneca Covid-19 Vaccine Shows Lower Efficacy Against South African Variant Of The Virus
Only limited protection against mild disease caused by the South African variant of the novel coronavirus was exhibited by the Cvoid-19 vaccine developed by AstraZeneca and the University of Oxford, said a spokesman for the British drug maker. This statement from the firm was issued following a report published in the Financial Times where it…









